Renalytix Plc
Renalytix Plc RENX.L Peers
See (RENX.L) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| RENX.L | £7.25 | N/A | 24M | -0.60 | -£0.12 | N/A |
| EMIS.L | £1,922.00 | +0.10% | 1.2B | 40.89 | £0.47 | N/A |
| 0MSD.L | £41.50 | +0.95% | 1.1B | 28.74 | £1.44 | N/A |
| CRW.L | £2,060.00 | -0.48% | 721.4M | 66.45 | £0.31 | +1.43% |
| INS.L | £829.00 | -0.12% | 199.4M | 59.21 | £0.14 | N/A |
| SMD.L | £58.00 | +10.48% | 79.7M | -14.50 | -£0.04 | N/A |
| KOO.L | £180.00 | -0.28% | 64.4M | 8.57 | £0.21 | N/A |
| COG.L | £37.50 | +4.00% | 15.7M | -9.37 | -£0.04 | N/A |
| INHC.L | £9.50 | N/A | 8.8M | -3.17 | -£0.03 | N/A |
| FDBK.L | £14.75 | -0.68% | 6.5M | -0.61 | -£0.24 | N/A |
Stock Comparison
RENX.L vs EMIS.L Comparison
RENX.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RENX.L stands at 24M. In comparison, EMIS.L has a market cap of 1.2B. Regarding current trading prices, RENX.L is priced at £7.25, while EMIS.L trades at £1,922.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RENX.L currently has a P/E ratio of -0.60, whereas EMIS.L's P/E ratio is 40.89. In terms of profitability, RENX.L's ROE is +2.96%, compared to EMIS.L's ROE of +0.24%. Regarding short-term risk, RENX.L is more volatile compared to EMIS.L. This indicates potentially higher risk in terms of short-term price fluctuations for RENX.L.